PURPOSE: Changes in body composition are commonly present in chronic obstructive pulmonary disease (COPD). The main aim of this study were to evaluate changes in body composition and the prevalence of pre-sarcopenia and sarcopenia in patients with COPD, compared with two control groups and correlate these parameters with indices of COPD severity (VEF1 and GOLD) and prognosis (BODE). METHODS: This was a cross-sectional study in COPD patients (DG) that undergone body composition assessment by DXA. Two control groups were used, smokers individuals without COPD (smokers group, SG), and healthy never smokers individuals (never smokers group, NSG). RESULTS: DG comprised 121 patients (65 women, mean age 67.9 ± 8.6 years). The percentage of total body fat mass (TFM) was significantly lower in DG in both genders, despite no difference in BMI. Both BMI and relative skeletal muscle mass index (RSMI) decreased according to the worsening of GOLD in men and women, as well as the TFM and total lean mass (TLM) in men. As BODE get worse, BMI and RSMI decreased in both sexes, as well as TLM in men. The prevalence of pre-sarcopenia in the DG was 46.3% and no different with controls. In DG 12.4% were sarcopenic. Patients with sarcopenia were older and had worse prognosis. Higher BODE prognostic index, higher the prevalence of sarcopenia (OR 3.5, 95% CI 1.06-11.56, p = 0.035). CONCLUSIONS: This study showed alterations in body composition parameters in patients with COPD. A high prevalence of sarcopenia and the association with worse prognostic index.
PURPOSE: Changes in body composition are commonly present in chronic obstructive pulmonary disease (COPD). The main aim of this study were to evaluate changes in body composition and the prevalence of pre-sarcopenia and sarcopenia in patients with COPD, compared with two control groups and correlate these parameters with indices of COPD severity (VEF1 and GOLD) and prognosis (BODE). METHODS: This was a cross-sectional study in COPDpatients (DG) that undergone body composition assessment by DXA. Two control groups were used, smokers individuals without COPD (smokers group, SG), and healthy never smokers individuals (never smokers group, NSG). RESULTS: DG comprised 121 patients (65 women, mean age 67.9 ± 8.6 years). The percentage of total body fat mass (TFM) was significantly lower in DG in both genders, despite no difference in BMI. Both BMI and relative skeletal muscle mass index (RSMI) decreased according to the worsening of GOLD in men and women, as well as the TFM and total lean mass (TLM) in men. As BODE get worse, BMI and RSMI decreased in both sexes, as well as TLM in men. The prevalence of pre-sarcopenia in the DG was 46.3% and no different with controls. In DG 12.4% were sarcopenic. Patients with sarcopenia were older and had worse prognosis. Higher BODE prognostic index, higher the prevalence of sarcopenia (OR 3.5, 95% CI 1.06-11.56, p = 0.035). CONCLUSIONS: This study showed alterations in body composition parameters in patients with COPD. A high prevalence of sarcopenia and the association with worse prognostic index.
Entities:
Keywords:
BODE; Body composition; COPD; GOLD; Sarcopenia
Authors: J R Guthrie; P R Ebeling; J L Hopper; E Barrett-Connor; L Dennerstein; E C Dudley; H G Burger; J D Wark Journal: Osteoporos Int Date: 1998 Impact factor: 4.507
Authors: Annemie M W J Schols; Roelinka Broekhuizen; Clarie A Weling-Scheepers; Emiel F Wouters Journal: Am J Clin Nutr Date: 2005-07 Impact factor: 7.045
Authors: Mitja Lainscak; Stephan von Haehling; Wolfram Doehner; Irena Sarc; Tina Jeric; Kristina Ziherl; Mitja Kosnik; Stefan D Anker; Stanislav Suskovic Journal: J Cachexia Sarcopenia Muscle Date: 2011-03-01 Impact factor: 12.910
Authors: Thuy-Tien Dam; Katherine W Peters; Maren Fragala; Peggy M Cawthon; Tamara B Harris; Robert McLean; Michelle Shardell; Dawn E Alley; Anne Kenny; Luigi Ferrucci; Jack Guralnik; Douglas P Kiel; Steve Kritchevsky; Maria T Vassileva; Stephanie Studenski Journal: J Gerontol A Biol Sci Med Sci Date: 2014-05 Impact factor: 6.053
Authors: Aida Venado; Charles McCulloch; John R Greenland; Patricia Katz; Allison Soong; Pavan Shrestha; Steven Hays; Jeffrey Golden; Rupal Shah; Lorriana E Leard; Mary Ellen Kleinhenz; Jasleen Kukreja; Lydia Zablotska; Isabel E Allen; Kenneth Covinsky; Paul Blanc; Jonathan P Singer Journal: J Heart Lung Transplant Date: 2019-03-18 Impact factor: 10.247
Authors: Yanxia Han; Zhenyun Wu; Yi Chen; Yanan Kan; Min Geng; Nuo Xu; Hongying Qian; Hai Fang Wang; Meie Niu Journal: Medicine (Baltimore) Date: 2019-10 Impact factor: 1.889
Authors: Elizabeth Benz; Katerina Trajanoska; Josje D Schoufour; Lies Lahousse; Emmely W de Roos; Natalie Terzikhan; Carolina Medina-Gomez; Katia Verhamme; Ross Williams; Bruno H Stricker; Oscar H Franco; M Arfan Ikram; Fernando Rivadeneira; Guy Brusselle Journal: ERJ Open Res Date: 2021-03-08
Authors: Aleksandra Kaluźniak-Szymanowska; Roma Krzymińska-Siemaszko; Ewa Deskur-Śmielecka; Marta Lewandowicz; Beata Kaczmarek; Katarzyna Wieczorowska-Tobis Journal: Nutrients Date: 2021-12-23 Impact factor: 5.717
Authors: Walter Sepúlveda-Loyola; Christian Osadnik; Steven Phu; Andrea A Morita; Gustavo Duque; Vanessa S Probst Journal: J Cachexia Sarcopenia Muscle Date: 2020-08-30 Impact factor: 12.910